Revenue Growth
For the third quarter of fiscal 2025, Inotiv saw a year-over-year revenue increase of 23.5%, reaching $130.7 million compared to $105.8 million in the third quarter of fiscal 2024.
RMS Segment Performance
The RMS segment revenue increased by $21 million or 34.1% improvement over the prior year quarter.
DSA Segment Growth
DSA segment revenue increased by $3.9 million or 8.9% compared to the same period in fiscal 2024.
Improved EBITDA
EBITDA for the quarter was $11.6 million compared to $0.1 million in Q3 of fiscal 2024.
Discovery Awards Increase
Discovery awards increased 31.3% over the same period a year ago.
Positive Net Book-to-Bill Ratio
For all of DSA, the positive quarterly net book-to-bill was 1.07x.
ALAC Accreditation
Updated ALAC accreditation for NHP facilities in Texas, noted for having an exemplary program of laboratory animal care and use.